SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950123-10-082280
Filing Date
2010-08-30
Accepted
2010-08-30 16:34:51
Documents
2
Group Members
QUAKER BIOVENTURES CAPITAL II, L.P.QUAKER BIOVENTURES CAPITAL II, LLCQUAKER BIOVENTURES II, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G c05444sc13g.htm SC 13G 54813
2 EXHIBIT 1 c05444exv99w1.htm EX-99.1 5826
  Complete submission text file 0000950123-10-082280.txt   62692
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Subject) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82163 | Film No.: 101047135
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G